Syros Pharmaceuticals, Inc. - common stock (SYRS) Social Stream
SYROS PHARMACEUTICALS INC (SYRS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SYRS.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 5 | $23 | $9 | $17.2 | $6.71 | 156.33% |
| 2021-12-13 | 6 | $23 | $9 | $17.2 | $6.71 | 156.33% |
| 2022-01-03 | 6 | $23 | $9 | $17.6 | $6.71 | 162.3% |
| 2022-05-16 | 6 | $23 | $9 | $16 | $6.71 | 138.45% |
| 2022-05-17 | 6 | $23 | $9 | $13.5 | $6.71 | 101.19% |
| 2022-06-07 | 5 | $19 | $9 | $11.6 | $6.71 | 72.88% |
| 2022-08-09 | 5 | $19 | $6 | $10.8 | $6.71 | 60.95% |
| 2022-08-10 | 5 | $19 | $3 | $9.6 | $6.71 | 43.07% |
| 2022-09-12 | 5 | $190 | $30 | $96 | $6.71 | 1330.7% |
| 2022-09-19 | 5 | $190 | $27 | $81.4 | $6.71 | 1113.11% |
| 2022-11-06 | 5 | $100 | $27 | $55.4 | $6.71 | 725.63% |
| 2022-11-14 | 6 | $100 | $27 | $55.4 | $6.71 | 725.63% |
| 2022-11-15 | 5 | $100 | $15 | $39.666 | $6.71 | 491.15% |
| 2022-12-10 | 6 | $100 | $15 | $39.666 | $6.71 | 491.15% |
| 2023-01-09 | 6 | $100 | $15 | $38.5 | $6.71 | 473.77% |
| 2023-01-26 | 6 | $100 | $15 | $37.833 | $6.71 | 463.83% |
| 2023-05-11 | 6 | $100 | $13 | $36.666 | $6.71 | 446.44% |
| 2023-08-09 | 5 | $60 | $15 | $26.75 | $6.71 | 298.66% |
| 2023-10-03 | 5 | $48 | $7 | $21.5 | $6.71 | 220.42% |
| 2023-11-15 | 5 | $48 | $7 | $23.333 | $6.71 | 247.73% |
| 2023-12-22 | 5 | $37 | $13 | $21.666 | $6.71 | 222.89% |
The Trend in the Analyst Price Target
SYRS's average price target has moved down $18 over the prior 13 months.
SYRS reports an average of 708.46% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-26 | 6 | 100 | 15 | 37.833 | 4.42 | 755.95% |
| 2023-05-11 | 6 | 60 | 13 | 24.000 | 3.32 | 622.89% |
| 2023-08-09 | 5 | 60 | 11 | 25.500 | 3.73 | 583.65% |
| 2023-10-03 | 5 | 48 | 7 | 21.500 | 2.80 | 667.86% |
| 2023-12-06 | 5 | 48 | 13 | 25.333 | 4.02 | 530.17% |
SYRS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 40 months, SYRS's average broker recommendation rating improved by 0.57.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- SYRS has a lower variance in analysts' estimates than -2431.5% of all US stocks.
- In the context of all US stocks, SYROS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 2356.65% of them.
- In the context of stocks in the small market cap category, SYROS PHARMACEUTICALS INC's average analyst price target is greater than 1707.15% of them.
- In the context of Healthcare stocks, SYROS PHARMACEUTICALS INC's number of analysts covering the stock is greater than 769.32% of them.
Stocks similar to SYROS PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CLSD, MRKR, and SYBX.
View All Top Stocks by Price Target
Is SYRS a Buy, Hold or Sell? See the POWR Ratings now!